Tildrakizumab (Anti-IL-23a)

Ask supplier a question | View on supplier's website

Tildrakizumab (Anti-IL-23a) is a humanized monoclonal antibody directed against the p19 protein subunit of interleukin-23 (IL-23), with immunomodulating activity. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2437
Sku #	A2437-1mg
Pricing	1mg, $370.00

Feedback